Ectica Welcomes You With Free VIP Registration to Proventa’s Oncology Strategy Meeting USA 2022
Ectica Technologies is delighted to sponsor the 5th Annual Oncology Strategy Meeting organized by Proventa International taking place on May
Read moreEctica Technologies is delighted to sponsor the 5th Annual Oncology Strategy Meeting organized by Proventa International taking place on May
Read moreTremelimumab, in conjunction with Imfinzi, has been accepted under priority review for patients with unresectable liver cancer in the United
Read moreAmerican multinational pharmaceutical company Bristol Myers Squibb has announced that OpdualagTM , a new, first-in-class, fixed-dose combination of nivolumab and relatlimab, administered as one intravenous infusion,
Read moreTinytag temperature data loggers are being utilised for the monitoring of vaccines and medications through the pharmaceutical cold chain. Temperature
Read moreWith the EchoLUTION SARS-CoV-2 RNA Kit, the PCR test of COVID-19 samples can be drastically accelerated. Ultra-fast COVID-19 PCR testing
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe first doses of an experimental HIV vaccine antigen have been provided in a clinical study at George Washington University
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read morePfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read moreBased on data obtained from Phase II and the Phase I studies, Abecma has received approval in Japan for the
Read more